as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

0.56%
Downside
0.54%
Upside

52 Week's Low
52 Week's High

21.69%
Downside
8.87%
Upside

Check Novartis Ag market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$238.3B
EPS (TTM)
8.959
Dividend Yield
3.11%
Quarterly Earnings Growth YOY
0.29%
PE Ratio (TTM)
16.66
Industry PE ratio
18.176666666666666
PEG Ratio
1.3644
EBITDA
22.9B
Revenue (TTM)
56.4B
Profit Margin
25.53%
Return On Equity TTM
32.62%
Track how Novartis Ag P/E has moved over time to understand its valuation trends.
Novartis Ag in the last 5 years
Lowest (12.84x)
March 31, 2025
Today (16.66x)
October 31, 2025
Industry (18.18x)
October 31, 2025
Highest (15.63x)
March 31, 2021
Today’s Price to Earnings Ratio: 16.66x
Compare market cap, revenue, PE, and other key metrics of Novartis Ag with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $238.3B | 57.03% | 16.66 | 25.53% | |
| BUY | $757.1B | 547.32% | 55.23 | 25.91% | |
| BUY | $397.7B | 168.16% | 107.72 | 6.45% | |
| BUY | $449.6B | 37.88% | 18.01 | 27.26% | |
| BUY | $232.2B | 56.64% | 13.21 | 35.61% | 
The Novartis Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novartis Ag investment value today
Current value as on today
₹1,18,831
Returns
₹18,831
(+18.83%)
Returns from Novartis Ag Stock
₹13,164 (+13.16%)
Dollar Returns*
₹5,667 (+5.67%)
Based on 32 analysts
50.00%
Buy
43.75%
Hold
6.25%
Sell
Based on 32 analysts, 50% of analysts recommend a 'BUY' rating for Novartis Ag. Average target price of $124.65
Get share price movements and forecasts by analysts on Novartis Ag.
What analysts predicted
1.59%UPSIDE
Target Price
$124.65
Current Price
$122.67
Analyzed by
32 Analysts
Target
$124.65
Novartis Ag target price $124.65, a slight upside of 1.59% compared to current price of $122.67. According to 32 analysts rating.
Investment in Novartis Ag Shares on INDmoney has grown by 122.41% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:122.41% versus previous 30 day period
Search interest for Novartis Ag Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD

Today's Timeline - 29 October
Wed, 09:37 AM
-Novartis reports strong Q3 2025 earnings with 8% net sales growth and 23% increase in net income.
Wed, 08:11 PM
-Novartis presents positive ianalumab data in Sjogrens disease, achieving primary objectives in Phase 3 trials.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTProfit Spike

Novartis AG has shown a positive trend in its net profit over the last three quarters. The net profit rose from $2.81 billion to $4.04 billion, reflecting an average increase of 16.3% per quarter.
 POSITIVE IMPACT
POSITIVE IMPACTRevenue Rich

Novartis Ag has shown consistent growth in revenue over the past 7 quarters. The revenue increased from $11.77 billion to $14.83 billion, averaging a rise of 3.7% each quarter.
 POSITIVE IMPACT
POSITIVE IMPACTBest in 3 Years

In the last 3 years, NVS has outperformed top 5 stocks with highest market-cap in its industry
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Johnson & Johnson has given 16.7% return, outperforming this stock by 4.3%
 NEGATIVE IMPACT
NEGATIVE IMPACTPrice Dip

In the last 7 days, NVS stock has moved down by -6.6%
| Organisation | Novartis Ag | 
| Headquarters | Lichtstrasse 35, Basel, Switzerland, 4056 | 
| Industry | Health Technology | 
| CEO | Dr. Vasant Narasimhan M.D. | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Patrick Horber M.D. | President of International | 
| Ms. Sloan Simpson | Global Head of Investor Relations | 
| Dr. Robert Kowalski Pharm.D. | Chief People & Organization Officer | 
| Dr. Linda W. Armstrong M.D. | Global Head of Respiratory Development | 
| Mr. Victor Bulto | President of US | 
| Mr. Harry Kirsch | Chief Financial Officer | 
| Dr. Steffen Lang Ph.D. | President of Operations | 
| Paul Penepent | Head of Group Financial Reporting and Accounting | 
| Ms. Karen L. Hale | Chief Legal & Compliance Officer | 
| Dr. Vasant Narasimhan M.D. | Chief Executive Officer | 
Novartis Ag share price today is $122.67 as on at the close of the market. Novartis Ag share today touched a day high of $123.33 and a low of $121.98.
Novartis Ag share touched a 52 week high of $133.55 on and a 52 week low of $96.06 on . Novartis Ag stock price today i.e. is closed at $122.67,which is 8.15% down from its 52 week high and 27.70% up from its 52 week low.
Novartis Ag market capitalisation is $0.24T as on .
Indian investors can start investing in Novartis Ag (NVS) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Novartis Ag stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Novartis Ag share’s latest price of $122.67 as on October 31, 2025 at 1:29 am IST, you will get 0.0815 shares of Novartis Ag. Learn more about
          
            fractional shares .
        
Novartis Ag stock has given 57.03% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?